Qatar · Startup
Denovo Sciences
Summary
Business overview
Denovo Sciences builds AI-powered technologies for first-principles, structure-based drug discovery, designing small-molecule candidates where conventional methods fail.
Business activities
Not available
Registered trade names
Not available
Legal
Registration and legal
- Registry number
- Not available
- Legal form
- Startup
- Incorporated
- Not available
- Registry authority
- Not available
- Licence status
- Not available
- Licence expiry
- Not available
- Share capital
- Not available
- Fiscal year end
- Not available
- Operational status
- Active
- Country
- Qatar (QA)
- Classification
- Startup
- Sub-classification
- Not available
Footprint
Operations and locations
- Headquarters
- Not available
- Employees
- Not available
- Operating languages
- Not available
- Licensed locations
- Not available
- Active branches
- Not available
- Cities covered
- Not available
Branch register
No branch licences on record.
Office locations
Office
Al Gharrafa Street, Al Rayyan, Education City, Doha, Qatar
Office
138/2 Verin Antarain, Yerevan, Armenia
Office
Qatar Science and Technology Park, 210000 Doha, Qatar
Public website
Estimates
Financials
- Revenue, latest year
- $00,000,000
- Revenue, prior year
- $00,000,000
- Year on year growth
- 00%
- Profitability
- ••••••••
- Credit risk band
- •• ••••
- Funding rounds
- •••• ••••
Premium data point
Revenue history, growth, profitability, credit banding and funding rounds are premium data points.
Unlock for $10 / monthPremium
Signals and buying intent
- Buying intent score
- 00 / 100
- Trend
- ••••••
- Best time to reach out
- •••••• ••••••
Topics being researched
•••••• •••••••• ••••• •••••• ••••••••
•••••••• •••••• •••• ••••••••
••••• ••••••••• •••••• ••••• •••••••• ••••••
•••••••• •••••• •••• ••••••••
••••• ••••••••• •••••• ••••• •••••••• ••••••
•••••••• •••••• •••• ••••••••
••••• ••••••••• •••••• ••••• •••••••• ••••••
Premium data point
Buying intent scoring, researched topics, outreach timing and the dated signal feed are released with premium access.
Unlock for $10 / monthLeadership
Decision makers (13)
Hamlet Khachatryan
Computational Biologist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Hovakim Zakaryan
Co-Founder, CEO
Email: name.surname@company.qa
Direct line: +974 0000 0000
Hovhannes Matevosyan
Computational Chemist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Irina Tirosyan
Senior Data Scientist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Julia Borzunova
Computational Biologist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Marusya Ayvazyan
Computational Biologist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Mher Matevosyan
Co-Founder, CTO
Email: name.surname@company.qa
Direct line: +974 0000 0000
Narek Petrosyan
Computational Chemist
Email: name.surname@company.qa
Direct line: +974 0000 0000
See More
Grant Programs Manager
manager
Email: name.surname@company.qa
Direct line: +974 0000 0000
Smbat Gevorgyan
Computational Biologist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Vahe Petrosyan
Data Scientist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Vardan Harutyunyan
Co-founder, CAIO
Email: name.surname@company.qa
Direct line: +974 0000 0000
Yeva Gabrielyan
Senior Data Scientist
Email: name.surname@company.qa
Direct line: +974 0000 0000
Reporting structure
Hamlet Khachatryan
Computational Biologist
Hovakim Zakaryan
Co-Founder, CEO
Hovhannes Matevosyan
Computational Chemist
Irina Tirosyan
Senior Data Scientist
Julia Borzunova
Computational Biologist
Marusya Ayvazyan
Computational Biologist
Mher Matevosyan
Co-Founder, CTO
Narek Petrosyan
Computational Chemist
See More
Grant Programs Manager
Smbat Gevorgyan
Computational Biologist
Vahe Petrosyan
Data Scientist
Vardan Harutyunyan
Co-founder, CAIO
Yeva Gabrielyan
Senior Data Scientist
Premium data point
Direct work emails and phone numbers for every decision maker are released with premium access.
Unlock for $10 / monthNetwork
Relationships and partnerships
- Parent company
- Independent entity
- Subsidiaries
- None on record
- Group structure
- Standalone
Partnerships
Weill Cornell Medicine-Qatar
Collaboration to discover drug candidates for homocystinuria, announced October 2025
SourceCollaboration to discover drug candidates for homocystinuria, announced October 2025
SourceMankind Pharma
Strategic collaboration to launch AI-led drug discovery programme, announced July 2026
SourceFlagship Pioneering
Partner/investor in AI drug discovery platform
SourceOxford University
Research partnership
SourceCIRI
Research partnership
SourceCHUV (Centre Hospitalier Universitaire Vaudois)
Research partnership
SourceAgency
Partner organization
SourceAlchemist Doha
Investor - $1M investment in 2025
SourceBerkeley SkyDeck
Investor/Accelerator
SourceBAJ Accelerator
Investor/Accelerator
SourceChuv
oxford
Weill Cornell
Footer
Email
Map Location
eye
Key clients
Not available
Competitors
Not available
Detected stack
Technology
Cloud and hosting
•••••• ••••••
Business systems
•••••• ••••••
Customer and marketing
•••••• ••••••
Premium data point
Detected cloud, business, marketing, payment and security technologies are premium data points.
Unlock for $10 / monthRelated records
Similar companies in Qatar
Common questions
Frequently asked questions about Denovo Sciences
Is Denovo Sciences an active registered company in Qatar?
Denovo Sciences is recorded as active in the Qatar company register. Varosyan LLC monitors the registry continuously, so a status change appears here within minutes of the source publishing it.
What does Denovo Sciences do?
Denovo Sciences builds AI-powered technologies for first-principles, structure-based drug discovery, designing small-molecule candidates where conventional methods fail. It is classified under Startup.
Who leads Denovo Sciences?
Hamlet Khachatryan is listed as Computational Biologist of Denovo Sciences. The record covers 13 decision makers with titles and reporting lines; direct work emails and phone numbers are premium data points.
Is Denovo Sciences company data free to access on Varosyan LLC?
Yes. The full registration record, classification, locations and leadership names are free to read, and a free account unlocks corporate contact details. Premium access at $10 per month adds direct contacts for decision makers, buying signals, financial estimates and unlimited downloads.